Anemia and iron metabolism disorders after single anastomosis sleeve ileal (SASI) bypass. Is it a real problem? - Top-Institutions - MDSpire

Anemia and iron metabolism disorders after single anastomosis sleeve ileal (SASI) bypass. Is it a real problem?

  • By

  • Joanna Parkitna

  • Artur Binda

  • Agnieszka Gonciarska

  • Paweł Jaworski

  • Emilia Kudlicka

  • Krzysztof Barski

  • Karolina Wawiernia

  • Piotr Jankowski

  • Michał Wąsowski

  • Alina Kuryłowicz

  • Wiesław Tarnowski

  • June 21, 2024

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Disorders
    • Nutritional Science

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Bariatric Surgery
    • Endocrinology
    • Nutrition

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Bariatric Surgery
    • Gastroenterology
    • Hematology

  • #4

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Medicine
    • Nutrition

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Bariatric Surgery
    • Metabolic Disorders
    • Nutrition

Original Source(s)

Anemia and iron metabolism disorders after single anastomosis sleeve ileal (SASI) bypass. Is it a real problem?

  • by Joanna Parkitna, Artur Binda, Agnieszka Gonciarska, Paweł Jaworski, Emilia Kudlicka, Krzysztof Barski, Karolina Wawiernia, Piotr Jankowski, Michał Wąsowski, Alina Kuryłowicz, Wiesław Tarnowski

  • June 21, 2024

Related Content

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care

The premise that GLP-1 receptor agonists are replacing bariatric surgery for weight management is not just oversimplified; it’s wrong.

  • by

  • April 30, 2026

  • 6 min
Robotic hand-sewn vs. laparoscopic linear-stapled Roux-en-Y gastric bypass: a propensity score-matched analysis of primary and conversion cases